Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel

Experienced legal leader brings deep expertise in governance, strategic transactions, and risk management to support Vor Bio’s growthCAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. “We are delighte ...